BrainPET Accelerator
BrainPET Accelerator
Comprehensive Imaging Program
Comprehensive Imaging Program
Compact Brain PET
for Outpatient Imaging
Compact
Brain PET
for Outpatient Imaging
NeuroLF takes amyloid confirmation off whole-body scanners.
At equivalent image quality.
The Alzheimer's Confirmation
Bottleneck
PET Imaging is established as a standard of care in determining eligibility for Alzheimer's disease treatments.
With an estimated 9 million US adults carrying amyloid plaque, demand for confirmation imaging is accelerating fast.
For 2026, there's a projected 4x acceleration in PET confirmation.
Without dedicated outpatient capacity, this volume lands on full-body scanners already running at capacity.
~0M
~0M
Adults Living
with Amyloid Buildup
0x
0x
Projected Growth in Alzheimer's DMT Prescription
+0% YoY
+0% YoY
Growth in Brain PET Scan Demand
+0 months
+0 months
On Waitlist for
a Confirmation PET Scan
The Alzheimer's Confirmation
Bottleneck
PET Imaging is established as a standard of care in determining eligibility for Alzheimer's disease treatments.
With an estimated 9 million US adults carrying amyloid plaque, demand for confirmation imaging is accelerating fast.
For 2026, there's a projected 4x acceleration in PET confirmation.
Without dedicated outpatient capacity, this volume lands on full-body scanners already running at capacity.
~0M
~0M
Adults Living
with Amyloid Buildup
0x
0x
Projected Growth in Alzheimer's DMT Prescription
+0% YoY
+0% YoY
Growth in Brain PET Scan Demand
+0 months
+0 months
On Waitlist for
a Confirmation PET Scan
The Alzheimer's Confirmation
Bottleneck
PET Imaging is established as a standard of care in determining eligibility for Alzheimer's disease treatments.
With an estimated 9 million US adults carrying amyloid plaque, demand for confirmation imaging is accelerating fast.
For 2026, there's a projected 4x acceleration in PET confirmation.
Without dedicated outpatient capacity, this volume lands on full-body scanners already running at capacity.
~0M
~0M
Adults Living
with Amyloid Buildup
0x
0x
Projected Growth in Alzheimer's DMT Prescription
+0% YoY
+0% YoY
Growth in Brain PET Scan Demand
+0 months
+0 months
On Waitlist for
a Confirmation PET Scan
The Brain PET Scanner
that Fits Your Outpatient Imaging
NeuroLF®
Purpose-built for Brain PET Imaging.
FDA Cleared & CE Marked
Ultra-compact – 5.4 x 7.0 x 2.4 ft
Standard 110V Power Outlet
Minimal Site Prep
Minimal shielding needs
Patient-friendly upright design
Total footprint: ~175 sq ft
(Scanning + Operator Room)
NeuroLF®
NeuroLF®
Purpose-built for Brain PET Imaging.
FDA Cleared & CE Marked
Ultra-compact – 5.4 x 7.0 x 2.4 ft
Standard 110V Power Outlet
Minimal Site Prep
Minimal shielding needs
Patient-friendly upright design
Total footprint: ~175 sq ft (Scanning + Operator Room)
Equivalent quantitative centiloid calculation resulting in equivalent diagnosis. Minor variability within standard deviation range.
Michael Shriver, MD
Director of Nuclear Medicine and Neuroradiologist,
Proscan-NCH Imaging, Naples, Florida
A Fully Managed Brain PET Model
Profitable from Year One
The BrainPET Accelerator Program
Site build-out
Site assessment, shielding, and installation. No construction project.
Site build-out
Site assessment, shielding, and installation. No construction project.
Regulatory compliance
RAM licensing, hot lab setup, and radiation safety — fully managed.
Regulatory compliance
RAM licensing, hot lab setup, and radiation safety — fully managed.
Technologist staffing
Certified nuclear medicine technologist included. No new hire, no training overhead.
Technologist staffing
Certified nuclear medicine technologist included. No new hire, no training overhead.
Radiotracer logistics
Same-day tracer delivery coordinated with a regional radiopharmacy.
Radiotracer logistics
Same-day tracer delivery coordinated with a regional radiopharmacy.
The Economics
$1M–$2.5M
Projected cumulative net profit over five years at moderate scan volumes.
$1M–$2.5M
Projected cumulative net profit over five years at moderate scan volumes.
$1M–$2.5M
Projected cumulative net profit over five years at moderate scan volumes.
Profitable from year one
At 30–40 amyloid scans per month, the program turns profitable in year one.
Profitable from year one
At 30–40 amyloid scans per month, the program turns profitable in year one.
$0 upfront
No capital outlay. Program costs align with scan volume, not a purchase.
$0 upfront
No capital outlay. Program costs align with scan volume, not a purchase.
One patient, full pathway
Confirmation and monitoring scans. Anti-amyloid therapy, MRI, all under one roof.
One patient, full pathway
Confirmation and monitoring scans. Anti-amyloid therapy, MRI, all under one roof.
NeuroLF Images
Amyloid Scan using NeuraCeq ®
(Life Molecular Imaging)
Image courtesy of University of Leipzig,
Medical Center, Leipzig, Germany
Amyloid Scan using Vizamyl ®
(GE Healthcare)
Image courtesy of Proscan Imaging,
Naples, Florida
Clear the Confirmation Backlog
Join the growing network of imaging centers
adding dedicated brain PET.
Blueprint for Success
Blueprint for Success
Launching our Alzheimer’s & Dementia Center with NeuroLF at its core represents a transformation in how we can serve patients experiencing memory loss and cognitive symptoms.
Dr. Branko Huisa
Founder and Medical Director,
The Neuron Clinic, San Marcos, California
Launching our Alzheimer’s & Dementia Center with NeuroLF at its core represents a transformation in how we can serve patients experiencing memory loss and cognitive symptoms.
Dr. Branko Huisa
Founder and Medical Director,
The Neuron Clinic, San Marcos, California
Launching our Alzheimer’s & Dementia Center with NeuroLF at its core represents a transformation in how we can serve patients experiencing memory loss and cognitive symptoms.
Dr. Branko Huisa
Founder and Medical Director,
The Neuron Clinic, San Marcos, California
FAQ
How much space is needed to install NeuroLF?
What’s included in the BrainPET Accelerator program?
What upfront investment is required to get started?
Why is now the right time to add amyloid PET imaging to Alzheimer’s care?